Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review-Reference-Cited by-同舟云学术

Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review

Published:2018-07 Issue:7 Volume:5 Page:e299-e309
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Buske Christian,Sadullah Shalal,Kastritis Efstathios,Tedeschi Alessandra,García-Sanz Ramón,Bolkun Lukasz,Leleu Xavier,Willenbacher Wolfgang,Hájek Roman,Minnema Monique C,Cheng Mei,Bilotti Elizabeth,Graef Thorsten,Dimopoulos Meletios A

Publisher

Elsevier BV

Subject

Hematology

Reference36 articles.

1. Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Buske;Ann Oncol,2013

2. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia;Owen;Semin Oncol,2003

3. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus;Dimopoulos;Blood,2014

4. How I treat Waldenstrom macroglobulinemia;Treon;Blood,2015

5. Overall survival and competing risks of death in patients with Waldenstrom macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database;Castillo;Br J Haematol,2015

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia;Journal of Clinical Oncology;2024-07-20

2. Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia;Blood Science;2024-01

3. Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström’s Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study;Advances in Therapy;2023-12-11

4. The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia;Hematology/Oncology Clinics of North America;2023-08

5. Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects;Annals of Hematology;2023-07-06